Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection

March 21, 2019

Ligand to Participate in Four Upcoming Investor Conferences

March 12, 2019

Ligand Provides Highlights from Today’s Analyst Day Event

March 12, 2019

Ligand Sells Promacta Assets and Royalty for $827 Million

March 5, 2019

Reminder: Ligand to Host Analyst Day on March 12th in New York City

February 21, 2019

Ligand Reports Fourth Quarter and Full Year 2018 Financial Results

February 7, 2019

Ligand Announces OmniAb® Partnership with Genagon Therapeutics

February 7, 2019

Ligand Announces Investment in Dianomi Therapeutics

February 4, 2019

Ligand Partner Seelos Therapeutics Becomes a Public Company

January 25, 2019

Ligand to Report Fourth Quarter and Full Year 2018 Results on February 7th

January 15, 2019

1
2
3
4
5
6
7
8
9
10
...38
Next »